What the new Labour government means for your money

Now that the dust has settled on the election we can take stock of what a Labour win will mean for your finances

MRNA Aug 2024 150.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.7000

-0.1100

(-13.58%)

At close: 11:38AM EDT

Loading interactive chart…

Zacks
Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More
GSK and CureVac (CVAC) are in the spotlight following a restructuring of their vaccine agreement.
Barrons.com
GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
CureVac is also eligible for future royalties. CureVac shares jumped 12% in early trading Wednesday, while GSK’s American depositary receipt slipped 0.2%. Shares of Moderna a leading mRNA vaccine manufacturer, were up 0.9%.
Zacks
Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
Moderna (MRNA) expects this funding to help support the development of its mRNA-based pre-pandemic vaccine against the H5 influenza virus, which is responsible for causing avian influenza or bird flu.